Global Percutaneous Mechanical Circulatory Support Devices Market Trends: Regional Breakdowns and Strategic Insights
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What is the Projected CAGR for the Percutaneous Mechanical Circulatory Support Devices Market Size from 2025 to 2034?
The market for percutaneous mechanical circulatory support devices has seen a significant expansion in recent years. The market, which was worth $2.26 billion in 2024, is expected to rise to $2.48 billion in 2025, registering a compound annual growth rate (CAGR) of 10.0%. Factors contributing to growth during the historic period include a rise in cardiovascular diseases, an ageing population, greater incidences of heart attacks, enhanced awareness and screening initiatives, and higher demand for heart pump devices.
The market size for percutaneous mechanical circulatory support devices is forecasted to experience substantial growth in the coming years. The market is anticipated to reach a value of $3.60 billion by 2029, increasing at a compound annual growth rate (CAGR) of 9.7%. Factors contributing to this expected growth during the forecast period include an increased need for long-term mechanical circulatory support, a rise in healthcare spending, growing numbers of individuals with diabetes and obesity, an increased demand for heart transplants, and wider acceptance of percutaneous procedures. Other influential trends during the forecast period comprise advancements in pump and cardiac support technologies, progress in minimally invasive medical technologies, and creation of biocompatible material.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Percutaneous Mechanical Circulatory Support Devices Market?
An upsurge in cardiovascular diseases is predicted to boost the growth trajectory of the percutaneous mechanical circulatory support devices market. These diseases collectively involve disorders impacting the heart and blood vessels, including coronary artery disease, heart failure, heart attacks, stroke, and elevated blood pressure. The escalating incidence rates of cardiovascular conditions can be linked to an aging demographic, unhealthy lifestyle habits, obesity, hypertension, and genetic susceptibility. Percutaneous mechanical circulatory support devices are employed in treating cardiovascular diseases to enhance cardiac functionality, alleviate heart strain, and help facilitate recovery in severe heart conditions. As an example, in December 2023, the Australian Institute of Health and Welfare, a governmental agency in Australia, reported an increase in doctor-certified deaths due to coronary heart disease (CHD) to 14,100 in 2021 and subsequently to 14,900 in 2022. As such, the mounting incidence of cardiovascular diseases is catalyzing the growth of the percutaneous mechanical circulatory support (MCS) devices market.
Which Key Market Segments Comprise the Percutaneous Mechanical Circulatory Support Devices Market and Drive Its Revenue Growth?
The percutaneous mechanical circulatory support devices market covered in this report is segmented –
1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types
2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices
2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)
3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)
4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System
5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20921&type=smp
Which Areas Are Leading Regions in the Percutaneous Mechanical Circulatory Support Devices Market Expansion Across the Globe?
North America was the largest region in the percutaneous mechanical circulatory support devices market in 2024. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing the Percutaneous Mechanical Circulatory Support Devices Industry Evolution?
Leading firms in the percutaneous mechanical circulatory support devices market are striving to create groundbreaking solutions such as intra-aortic axial-flow devices to improve patient results and lessen surgical hazards. The intra-aortic axial-flow device, a form of percutaneous mechanical circulatory support device, is crafted to support the cardiovascular function by boosting the blood flow from the left ventricle to the aorta. For example, in February 2023, US medical device company Procyrion, Inc. revealed the successful inaugural human usage of their Aortix pump. This novel device aims to avert acute kidney injury in patients during cardiac surgery. Deployed via a catheter into the descending thoracic aorta, the Aortix pump elevates renal perfusion and reduces the cardiac stress during surgery. It manages to do so by simultaneously improving renal and systemic perfusion and decreasing heart strain, marking it as highly beneficial for patients with weak left ventricular function and kidney impairment. The Aortix pump, capable of pumping up to 5.0 liters per minute, is designed for temporary use in procedures like percutaneous coronary interventions (PCI).
View the full report here:
How Is the Percutaneous Mechanical Circulatory Support Devices Market Conceptually Defined?
Percutaneous mechanical circulatory support (pMCS) devices are minimally invasive systems used to temporarily assist or completely replace the pumping function of the heart. These devices are inserted through a catheter into blood vessels, typically via the femoral artery, and positioned in the heart to provide mechanical support during acute heart failure, cardiogenic shock, or high-risk cardiac interventions.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20921
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
